About this trial
An observational study to screen survivors of testicular cancer for late side effects including recurrence of cancer, second malignant neoplasms, cardiovascular, metabolic, hormonal and respiratory complications.
Patient Profile
Patients who have been discharged from Oncology services after successfully completing treatment and surveillance of testicular cancer
Where’s this trial being run?
Tallaght University Hospital
Can I join this study / trial?
The first step we recommend is to talk to your doctor or the cancer trials team at your hospital. You can find contact details for cancer trials research units in Ireland here.
It’s also a good idea to print this page and bring it with you to your appointment. It can help guide the conversation and remind you of what to ask. You may also want to talk to your family or friends about your options, as they can offer support as you make decisions.
For more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | SLECT |
|---|---|
| Number: | 23-09 |
| Full Title: | Long-term Sequelae of Testicular Cancer and Treatment |
| Principal Investigator: | Dr Muhammad Raheel Khan |
|---|---|
| Type: | Collaborative |
| Sponsor: | Tallaght University Hospital |
| Recruitment Started: |
Global: Ireland: April 2023 |
| Global Recruitment Target: | |
|---|---|
| Ireland Recruitment Target: | 150 |